Skip to search formSkip to main contentSkip to account menu

Anti-glaucoma Agent

Natural or synthetic Anti-glaucoma Agents relieve or prevent glaucoma, a condition characterized by increased intraocular pressure, excavation, and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
DESIGN OF OCULAR CONTROLLED RELEASE OCUSERTS OF BRINZOLAMIDE
The objective of research was to formulate and evaluate controlled release drug delivery system like ocuserts of Brinzolamide, an… 
2014
2014
Nipradilol promotes axon regeneration through S-nitrosylation of PTEN in retinal ganglion cells.
Nipradilol (Nip) is registered as an anti-glaucoma agent. More recently, a protective effect of Nip has been demonstrated in… 
2013
2013
Baicalein as a potential anti-glaucoma agent
2010
2010
Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea.
To evaluate the pharmacological properties of cilostazol (CLZ), we examined its intraocular pressure (IOP) -lowering effect. CLZ… 
Review
2008
Review
2008
[Studies on clinical pathophysiology of pseudophakic/aphakic eyes--a journey of 4 decades].
My prime years as an ophthalmologist began as intraocular lenses (IOLs) were just entering into the developmental stage, and I… 
2008
2008
HISTOPATHOLOGIC EVALUATION OF TRABECULECTOMY SPECIMENS AND SURGICAL RESULTS IN PATIENTS WITH CHRONIC PRIMARY GLAUCOMA
Purpose: To evaluate the histopathologic features of trabeculectomy specimens and the results of trabeculectomy in relation with… 
Highly Cited
2004
Highly Cited
2004
Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS.
2000
2000
Soft cannabinoid analogues as potential anti-glaucoma agents.
Cannabinoids have intraocular pressure (IOP) lowering effects, thus, they have a therapeutic potential in the treatment of… 
1993
1993
[The clinical evaluation of UF-021, a new prostaglandin related compound, in low tension glaucoma patients].
We administered UF-021 isopropyl unoprostone (Rescula) ophthalmic solution, a new prostaglandin-related compound developed as an… 
1992
1992
[The intraocular pressure lowering effects of UF-021, a novel prostaglandin related compound, in animals].
The ophthalmic solution of UF-021, a novel prostaglandin (PG) related compound, was investigated for its intraocular pressure… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)